AstraZeneca PLC
AstraZeneca PLC ZEG.DE Peers
See (ZEG.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZEG.DE | €127.95 | +0.63% | 198.4B | 29.41 | €4.35 | +2.14% |
| LLY.DE | €674.40 | +0.73% | 639.2B | 62.91 | €10.72 | +0.68% |
| JNJ.DE | €135.84 | +1.15% | 326.8B | 17.30 | €7.85 | +3.04% |
| 4AB.DE | €167.20 | +1.46% | 295.3B | 81.56 | €2.05 | +3.17% |
| 6MK.DE | €69.50 | +1.76% | 174.5B | 11.51 | €6.04 | +3.83% |
| AMG.DE | €255.15 | +0.22% | 137.2B | 26.58 | €9.60 | +3.32% |
| GIS.DE | €97.90 | -0.06% | 121.8B | 23.53 | €4.16 | +2.71% |
| PFE.DE | €20.62 | +0.98% | 117.2B | 17.04 | €1.21 | +6.87% |
| PFE.F | €20.59 | +1.58% | 117.1B | 17.16 | €1.20 | +6.88% |
| SNW.DE | €88.43 | +1.09% | 107.7B | 17.72 | €4.99 | +4.43% |
Stock Comparison
ZEG.DE vs LLY.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, LLY.DE has a market cap of 639.2B. Regarding current trading prices, ZEG.DE is priced at €127.95, while LLY.DE trades at €674.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas LLY.DE's P/E ratio is 62.91. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, ZEG.DE is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs JNJ.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, JNJ.DE has a market cap of 326.8B. Regarding current trading prices, ZEG.DE is priced at €127.95, while JNJ.DE trades at €135.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas JNJ.DE's P/E ratio is 17.30. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to JNJ.DE's ROE of +0.30%. Regarding short-term risk, ZEG.DE is less volatile compared to JNJ.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs 4AB.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, 4AB.DE has a market cap of 295.3B. Regarding current trading prices, ZEG.DE is priced at €127.95, while 4AB.DE trades at €167.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas 4AB.DE's P/E ratio is 81.56. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to 4AB.DE's ROE of +0.96%. Regarding short-term risk, ZEG.DE is less volatile compared to 4AB.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs 6MK.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, 6MK.DE has a market cap of 174.5B. Regarding current trading prices, ZEG.DE is priced at €127.95, while 6MK.DE trades at €69.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas 6MK.DE's P/E ratio is 11.51. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to 6MK.DE's ROE of +0.38%. Regarding short-term risk, ZEG.DE is less volatile compared to 6MK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs AMG.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, AMG.DE has a market cap of 137.2B. Regarding current trading prices, ZEG.DE is priced at €127.95, while AMG.DE trades at €255.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas AMG.DE's P/E ratio is 26.58. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to AMG.DE's ROE of +0.66%. Regarding short-term risk, ZEG.DE is less volatile compared to AMG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs GIS.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, GIS.DE has a market cap of 121.8B. Regarding current trading prices, ZEG.DE is priced at €127.95, while GIS.DE trades at €97.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas GIS.DE's P/E ratio is 23.53. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to GIS.DE's ROE of +0.25%. Regarding short-term risk, ZEG.DE is less volatile compared to GIS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs PFE.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, PFE.DE has a market cap of 117.2B. Regarding current trading prices, ZEG.DE is priced at €127.95, while PFE.DE trades at €20.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas PFE.DE's P/E ratio is 17.04. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, ZEG.DE is less volatile compared to PFE.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs PFE.F Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, PFE.F has a market cap of 117.1B. Regarding current trading prices, ZEG.DE is priced at €127.95, while PFE.F trades at €20.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas PFE.F's P/E ratio is 17.16. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, ZEG.DE is less volatile compared to PFE.F. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs SNW.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, SNW.DE has a market cap of 107.7B. Regarding current trading prices, ZEG.DE is priced at €127.95, while SNW.DE trades at €88.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas SNW.DE's P/E ratio is 17.72. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to SNW.DE's ROE of +0.08%. Regarding short-term risk, ZEG.DE is less volatile compared to SNW.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs BRM.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, BRM.DE has a market cap of 86.4B. Regarding current trading prices, ZEG.DE is priced at €127.95, while BRM.DE trades at €42.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas BRM.DE's P/E ratio is 18.06. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to BRM.DE's ROE of +0.32%. Regarding short-term risk, ZEG.DE is less volatile compared to BRM.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs BAYN.SG Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, BAYN.SG has a market cap of 26B. Regarding current trading prices, ZEG.DE is priced at €127.95, while BAYN.SG trades at €26.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to BAYN.SG's ROE of -0.08%. Regarding short-term risk, ZEG.DE is less volatile compared to BAYN.SG. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs BAYN.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, BAYN.DE has a market cap of 26B. Regarding current trading prices, ZEG.DE is priced at €127.95, while BAYN.DE trades at €26.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas BAYN.DE's P/E ratio is -7.96. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to BAYN.DE's ROE of -0.10%. Regarding short-term risk, ZEG.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs IDP.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, IDP.DE has a market cap of 17.1B. Regarding current trading prices, ZEG.DE is priced at €127.95, while IDP.DE trades at €116.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas IDP.DE's P/E ratio is 13.09. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to IDP.DE's ROE of +0.09%. Regarding short-term risk, ZEG.DE is less volatile compared to IDP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.
ZEG.DE vs GS7.DE Comparison
ZEG.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZEG.DE stands at 198.4B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, ZEG.DE is priced at €127.95, while GS7.DE trades at €20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZEG.DE currently has a P/E ratio of 29.41, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, ZEG.DE's ROE is +0.19%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, ZEG.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for ZEG.DE.